您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Carbapenems APIs and the intermediates report

健康网讯：

General situation of Carbapenems APIs and the intermediates (4-AA)

Publisher: Beijing Orientbit Technology Co., Ltd.
Format:  Adobe PDF
Price:  $500
Contact:  Ms. Wu huifang   Mr. Bian Chenghua
Tel.: 86-10-68032463             Fax:  86-10-68052525
E-mail: bianch@healthoo.com   wuhf@healthoo.com

Index
1. Chinese market size of Carbapenems formulations
2. Export statistics of 4-AA and other intermediates (Side Chains for Ertapenem，meropenem, imipenem,Side chain for biapenem )
2.1 Export volume
2.2 Statistics by exporters
2.3 Statistics by destination country
3 Faropenem registration situation in China

Table 1 Chinese market size of Carbapenems formulations form 2003 to 2007
Table 2 Export volumes of 4-AA
Table 3 Statistics of 4-AA by exporters in 2007
Table 4 Statistics of 4-AA by exporters in first half year of 2008
Table 5 Statistics of 4-AA by destination country in 2007
Table 6 Statistics of 4-AA by destination country in first half year of 2008
Table 7 Export statistics of other intermediates in 2007
Table 8 Export statistics of other intermediates in first half year of 2008
Table 9 The companies approved to product Faropenem

Graph 1 Growth trend of Carbapenems formulations from 2003 to 2007
Graph 2 Sales values of the formulations of 4 Carbapenems
Graph 3 Export volumes of meropenem, Imipenem-Cilastatin, 4-AA
Graph 4 Market shares of Faropenem formulations in 2007

(total 9 pages)